These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33030015)

  • 1. Aptamer Generated by Cell-SELEX for Specific Targeting of Human Glioma Cells.
    Lin N; Wu L; Xu X; Wu Q; Wang Y; Shen H; Song Y; Wang H; Zhu Z; Kang D; Yang C
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9306-9315. PubMed ID: 33030015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of Nucleic Acid Aptamers Capable of Specifically Targeting Glioma Stem Cells via Cell-SELEX.
    Wu Q; Lin N; Tian T; Zhu Z; Wu L; Wang H; Wang D; Kang D; Tian R; Yang C
    Anal Chem; 2019 Jul; 91(13):8070-8077. PubMed ID: 31179688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developing Aptamers by Cell-Based SELEX.
    Catuogno S; Esposito CL; de Franciscis V
    Methods Mol Biol; 2016; 1380():33-46. PubMed ID: 26552814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of DNA Aptamers Recognizing EpCAM-Positive Prostate Cancer by Cell-SELEX for in vitro and in vivo MR Imaging.
    Zhong J; Ding J; Deng L; Xiang Y; Liu D; Zhang Y; Chen X; Yang Q
    Drug Des Devel Ther; 2021; 15():3985-3996. PubMed ID: 34584404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generating lung-metastatic osteosarcoma targeting aptamers for in vivo and clinical tissue imaging.
    Wang L; Li P; Xiao X; Li J; Li J; Yang HH; Tan W
    Talanta; 2018 Oct; 188():66-73. PubMed ID: 30029428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligonucleotide aptamers for glioma targeting: an update.
    Camorani S; Cerchia L
    Cent Nerv Syst Agents Med Chem; 2015; 15(2):126-37. PubMed ID: 25924917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An improved SELEX technique for selection of DNA aptamers binding to M-type 11 of Streptococcus pyogenes.
    Hamula CL; Peng H; Wang Z; Tyrrell GJ; Li XF; Le XC
    Methods; 2016 Mar; 97():51-7. PubMed ID: 26678795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic applications of gastric carcinoma cell aptamers in vitro and in vivo.
    Ding F; Guo S; Xie M; Luo W; Yuan C; Huang W; Zhou Y; Zhang XL; Zhou X
    Talanta; 2015 Mar; 134():30-36. PubMed ID: 25618637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a DNA Aptamer against Multidrug-Resistant Hepatocellular Carcinoma for
    Zhang L; Zhou L; Zhang H; Zhang Y; Li L; Xie T; Chen Y; Li X; Ling N; Dai J; Sun X; Liu J; Zhao J; Peng T; Ye M
    ACS Appl Mater Interfaces; 2021 Nov; 13(46):54656-54664. PubMed ID: 34779207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Highly Specific DNA Aptamer for RNase H2 from
    Li J; Gu J; Zhang H; Liu R; Zhang W; Mohammed-Elsabagh M; Xia J; Morrison D; Zakaria S; Chang D; Arrabi A; Li Y
    ACS Appl Mater Interfaces; 2021 Mar; 13(8):9464-9471. PubMed ID: 33410654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo fluorescence imaging of tumors using molecular aptamers generated by cell-SELEX.
    Shi H; Tang Z; Kim Y; Nie H; Huang YF; He X; Deng K; Wang K; Tan W
    Chem Asian J; 2010 Oct; 5(10):2209-13. PubMed ID: 20806314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An aptamer-based, fluorescent and radionuclide dual-modality probe.
    Zhang GX; Liu YL; Yang M; Huang WS; Xu JH
    Biochimie; 2020; 171-172():55-62. PubMed ID: 32081705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application.
    Gan Z; Roslan MAM; Abd Shukor MY; Halim M; Yasid NA; Abdullah J; Md Yasin IS; Wasoh H
    Biosensors (Basel); 2022 Oct; 12(11):. PubMed ID: 36354431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Cell-Specific Aptamers: Recent Advances and Insight into the Selection Procedures.
    Rahimizadeh K; AlShamaileh H; Fratini M; Chakravarthy M; Stephen M; Shigdar S; Veedu RN
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29186905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances of aptamers screened by Cell-SELEX in selection procedure, cancer diagnostics and therapeutics.
    Zhong Y; Zhao J; Li J; Liao X; Chen F
    Anal Biochem; 2020 Jun; 598():113620. PubMed ID: 32087127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Novel pH-Sensitive Multifunctional DNA Nanomedicine: An Enhanced and Harmless GD2 Aptamer-Mediated Strategy for Guiding Neuroblastoma Antitumor Therapy.
    Zhang L; Wang M; Zhu Z; Ding C; Chen S; Wu H; Yang Y; Che F; Li Q; Li H
    Int J Nanomedicine; 2021; 16():3217-3240. PubMed ID: 34007175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex target SELEX.
    Shamah SM; Healy JM; Cload ST
    Acc Chem Res; 2008 Jan; 41(1):130-8. PubMed ID: 18193823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell-SELEX and application research of a DNA aptamer against esophageal squamous cell carcinoma (ESCC) cell line TE-1.
    Jin B; Yang G; Guo Z; Chen Z; Liu Y; Li S; Chen H; Fang Y; Deng Y; He N
    Anal Methods; 2024 Jul; 16(28):4683-4690. PubMed ID: 38958106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamers evolved from cultured cancer cells reveal molecular differences of cancer cells in patient samples.
    Shangguan D; Cao ZC; Li Y; Tan W
    Clin Chem; 2007 Jun; 53(6):1153-5. PubMed ID: 17463173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer for imaging and therapeutic targeting of brain tumor glioblastoma.
    Delač M; Motaln H; Ulrich H; Lah TT
    Cytometry A; 2015 Sep; 87(9):806-16. PubMed ID: 26189784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.